Академический Документы
Профессиональный Документы
Культура Документы
Traduzindo
Fung AE, Lalwani GA, Rosenfeld PJ, et al. A variable dosing regimen with intra-vitreal
lucentis (ranibizumab) for neovascular age-related macular degeneration: one year
results of the PrONTO study. Am J Ophthlamol 2007.
At mesmo o estudo PRONTO que foi o precursor do tratamento varivel, e que teve
diversas falhas apontadas ao longo dos ltimos 10 anos, e que assume critrios no
to rgidos para tratamento preconizam:
These criteria were a loss of five letters or more on a standardized visual acuity
chart with evidence of any subretinal fluid on OCT, an increase in central retinal
thickness of 100 m or more on OCT, any evidence of new hemorrhage; new classic
CNV, or detection of fluid on OCT persisting 1 month after an injection.